NASDAQ: SPRY - ARS Pharmaceuticals, Inc.

六个月盈利: +7.8%
部门: Healthcare

促销时间表 ARS Pharmaceuticals, Inc.


关于公司

ARS Pharmaceuticals, Inc., биофармацевтическая компания, разрабатывает методы лечения пациентов и родителей, страдающих тяжелыми аллергическими реакциями. Компания разрабатывает neffy, безыгольный интраназальный назальный спрей с низкой дозой адреналина для пациентов и лиц, осуществляющих уход за ними, с аллергическими реакциями I типа, включая анафилаксию. Компания была основана в 2015 году и базируется в Сан-Диего, штат Калифорния.


IPO date 2020-12-04
ISIN US82835W1080
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://ars-pharma.com
Цена ао 11.26
每日价格变化: 0% (11.26)
每周价格变化: -0.7055% (11.34)
每月价格变化: -5.38% (11.9)
3个月内价格变化: -26.07% (15.23)
六个月内的价格变化: +7.8% (10.445)
每年价格变化: +89.56% (5.94)
3年内价格变化: +104.73% (5.5)
5年内价格变化: 0% (11.26)
10年价格变化: 0% (11.26)
年初以来价格变化: +0.5357% (11.2)

低估

姓名 意义 年级
P/S 17551.36 1
P/BV 2.28 6
P/E 0 0
EV/EBITDA -6.76 0
全部的: 3.13

效率

姓名 意义 年级
ROA, % -23.31 0
ROE, % -23.56 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.0041 10
全部的: 9.4

成长冲动

姓名 意义 年级
盈利能力 Revenue, % -99.83 0
盈利能力 Ebitda, % 199.76 10
盈利能力 EPS, % 123.38 10
全部的: 8

机构 体积 分享, %
Deerfield Management Company, L.P. (Series C) 11077927 11.69
Orbimed Advisors LLC. 8740887 9.22
FMR, LLC 5088253 5.37
SR One Capital Management, LP 4012903 4.23
Rubric Capital Management LP 3480712 3.67
RA Capital Management, L.P. 3009678 3.18
K2 Principal Fund, L.P. 2686490 2.83
Baker Brothers Advisors, LLC 2006451 2.12
Nextech Invest Ag 1910029 2.02
Vanguard Group Inc 1697637 1.79

ETF 分享, % 本年盈利能力, % 股息, %
Invesco Dorsey Wright SmallCap Momentum ETF 0.59575 33.91 0.61241
iShares Micro-Cap ETF 0.18438 13.79 1.54048
Invesco Nasdaq Biotechnology ETF 0.13872 28.58 0.8565
Future Tech ETF 0.13757 426.34 0.8416
Principal Healthcare Innovators ETF 0.13757 618.5 0.8416
Direxion Daily S&P Biotech Bull 3x Shares 0.10101 4067.92 0.25924
iShares MSCI USA Small-Cap Min Vol Factor ETF 0.09976 16.5 1.66828
ProShares Ultra Nasdaq Biotechnology 0.09046 51.7 0.85651
Avantis U.S Small Cap Equity ETF 0.0824 27.77 1.68271
Vanguard U.S. Momentum Factor ETF 0.06 27.18 1.05834
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.05874 31.36 1.41955
iShares Russell 2000 Growth ETF 0.05387 38.04 0.6026
Vanguard Russell 2000 Growth ETF 0.05 17.39 0.60264
Vanguard Russell 2000 ETF 0.02 14.37 1.48801
Schwab U.S. Small-Cap ETF 0.01776 13.35 1.51433
ProShares UltraPro Russell2000 0.01571 89.82 1.47873
Fidelity MSCI Health Care Index ETF 0.00716 0.1657 1.46057
Humankind US Stock ETF 0.00433 18.81 1.99919
ProShares Hedge Replication ETF 0.00422 5.92 1.47892
iShares Russell 3000 ETF 0.00174 23.61 1.43482
Schwab U.S. Broad Market ETF 0.00128 23.7 1.43354
Avantis U.S. Equity ETF 0.00092 20.45 1.59151
SPDR Portfolio MSCI Global Stock Market ETF 0.00051 15.66 2.19607
Dimensional U.S. Core Equity 2 ETF 0.00029 30.76 1.47098
Dimensional US Core Equity Market ETF 0.00016 30.98 1.40618
Dimensional U.S. Equity ETF 0.00008 31.53 1.3557
Vanguard Russell 3000 ETF 0 31.87 1.43817



导师 职称 支付 出生年份
Mr. Richard Lowenthal M.B.A., M.S., MSMSEL Founder, President, CEO & Director 908.83k 1966 (59 年)
Dr. Sarina Tanimoto M.B.A., M.D. Co-Founder & Chief Medical Officer 748.97k 1969 (56 年)
Mr. Eric Karas Chief Commercial Officer 618.61k 1973 (52 年)
Dr. Robert Bell Ph.D. Co-Founder & Chief Science Officer N/A
Ms. Kathleen D. Scott CPA Chief Financial Officer N/A
Mr. Brian T. Dorsey M.S. Chief Operations Officer N/A 1969 (56 年)
Mr. Alexander A. Fitzpatrick Esq. Chief Legal Officer & Secretary N/A 1967 (58 年)
Mr. Daniel Relovsky Senior Vice President of Marketing N/A
Mr. Justin Chakma Chief Business Officer & Secretary N/A 1990 (35 年)
Mr. Harris Kaplan M.B.A. Executive Vice President of Commercial Strategy N/A 1952 (73 年)

地址: United States, San Diego. CA, 11682 El Camino Real - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://ars-pharma.com